(1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate

We are (1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate CAS:361440-67-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate
CAS.NO:361440-67-7
Synonyms:
tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate

Molecular Formula:C11H18N2O3
Molecular Weight: 226.27200

Physical and Chemical Properties:
Density:1.228g/cm3
Boiling point: 388.9ºC at 760 mmHg
Melting point: /
Flash point:189.024ºC
Refractive index: 1.538

Specification:
Appearance: White to off-white crystalline powder
Purity:≥98%
Water:≤0.5%
Heavy metals:≤20 ppm
Loss on drying:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Saxagliptin CAS:361442-04-8
Intermediates of Saxagliptin hydrochloride CAS:709031-78-7

(1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate


Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.112197-15-6 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.174775-48-5 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.1084334-86-0 The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.

Related Products
Product Name
3-Amino-2-fluoropyridine View Details
(1S,2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene View Details
2-isocyanatoethyl 2-methylprop-2-enoate View Details
N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine manufacturer N-[[(1,1-Dimethylethyl)Amino]Carbonyl]-3-Methyl-L-Valine manufacturer Gallic acid manufacturer Dichloromethylsilane manufacturer 2-Bromo-3-fluoroanisole manufacturer